Cargando…

alpha-Synuclein: a Modulator During Inflammatory CNS Demyelination

Neuroinflammation and demyelination are hallmarks of several neurological disorders such as multiple sclerosis and multiple system atrophy. To better understand the underlying mechanisms of de- and regeneration in respective diseases, it is critical to identify factors modulating these processes. On...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuhbandner, Kristina, Hoffmann, Alana, González Alvarado, María Nazareth, Seyler, Lisa, Bäuerle, Tobias, Winkler, Jürgen, Linker, Ralf A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334286/ https://www.ncbi.nlm.nih.gov/pubmed/32207050 http://dx.doi.org/10.1007/s12031-020-01498-8

Ejemplares similares

α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
por: Ettle, Benjamin, et al.
Publicado: (2016)

The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination
por: Kinzel, Silke, et al.
Publicado: (2017)

Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy
por: Mészáros, Lisa, et al.
Publicado: (2021)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

Sentinel inflammatory demyelinating lesions preceding primary CNS lymphoma
por: TORRES, Danielle Mesquita, et al.
Publicado: (2021)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017)

The Temporal Expression Pattern of Alpha-Synuclein Modulates Olfactory Neurogenesis in Transgenic Mice
por: Schreglmann, Sebastian R., et al.
Publicado: (2015)

Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations
por: Kim, Ki Hoon, et al.
Publicado: (2022)

MK2 and Fas Receptor Contribute to the Severity of CNS Demyelination
por: Tietz, Silvia M., et al.
Publicado: (2014)

CNS Involvement in Chronic Inflammatory Demyelinating Polyneuropathy: Subtle Retinal Changes in Optical Coherence Tomography
por: Ingwersen, Jens, et al.
Publicado: (2021)

Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
por: Linker, Ralf A, et al.
Publicado: (2009)

Deciphering the Footprints of Autoimmunity in CNS Demyelinating Disorders
por: Netravathi, M
Publicado: (2022)

Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity
por: Xiang, Wei, et al.
Publicado: (2015)

Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons
por: Koch, J C, et al.
Publicado: (2015)

Melanoma Cell Adhesion Molecule Expressing Helper T Cells in CNS Inflammatory Demyelinating Diseases
por: Ikeguchi, Ryotaro, et al.
Publicado: (2021)

Binding of α-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes
por: Reyes, Juan F., et al.
Publicado: (2019)

Cuprizone does not induce CNS demyelination in nonhuman primates
por: Chen, Zhihong, et al.
Publicado: (2015)

Challenges in the diagnosis and treatment of CNS demyelinating disorders in Zambia
por: Miskin, Dhanashri P, et al.
Publicado: (2016)

Effects of CNS Demyelination and Myelin Recovery on Urinary Physiology
por: Ramasamy, Ramalakshmi, et al.
Publicado: (2020)

Anterior optic pathway pathology in CNS demyelinating diseases
por: Pisa, Marco, et al.
Publicado: (2022)

Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease
por: Denny, Lisa, et al.
Publicado: (2021)

Novel contributors to B cell activation during inflammatory CNS demyelination; An oNGOing process
por: Damianidou, Olympia, et al.
Publicado: (2022)

Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
por: Dening, Yanina, et al.
Publicado: (2022)

Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose
por: Hoffmann, Anna-Carin, et al.
Publicado: (2019)

Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy
por: Mandler, Markus, et al.
Publicado: (2015)

SUMOylation of Alpha-Synuclein Influences on Alpha-Synuclein Aggregation Induced by Methamphetamine
por: Zhu, Lin-nan, et al.
Publicado: (2018)

Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress
por: Menges, Stefanie, et al.
Publicado: (2017)

The choline pathway as a strategy to promote central nervous system (CNS) remyelination
por: Skripuletz, Thomas, et al.
Publicado: (2015)

Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease
por: Chastain, Emily M. L., et al.
Publicado: (2012)

Asymptomatic CNS demyelination related to TNF-α inhibitor therapy
por: Ali, Farwa, et al.
Publicado: (2016)

CNS-disseminated Angiostrongylus cantonensis mimicking atypical demyelinating disease
por: Long, Daniel, et al.
Publicado: (2019)

Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination
por: Pajoohesh-Ganji, Ahdeah, et al.
Publicado: (2020)

Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease
por: Torke, Sebastian, et al.
Publicado: (2020)

The microbiota regulates murine inflammatory responses to toxin-induced CNS demyelination but has minimal impact on remyelination
por: McMurran, Christopher E., et al.
Publicado: (2019)

Exploring the Gut-Brain Axis for the Control of CNS Inflammatory Demyelination: Immunomodulation by Bacteroides fragilis’ Polysaccharide A
por: Erturk-Hasdemir, Deniz, et al.
Publicado: (2021)

CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
por: Rinaldi, Virginia, et al.
Publicado: (2022)

Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
por: Sacino, Amanda N, et al.
Publicado: (2013)

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
por: White, Alice J., et al.
Publicado: (2018)

Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration
por: Van Rompuy, Anne-Sophie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hilrsln6bofluk6lj9n3fg3t03